Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

IMRALDI 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/IMRALDI 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA

Approved

STANDARD

IMRALDI 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA

Samsung Bioepis Nl B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 21, 2022
Approval ID: b186b7e17f7539ca
Company: Samsung Bioepis Nl B.V.
Type: Standard

Approval Details

Approval Id: b186b7e17f7539ca
Drug Cima Aemps Name: IMRALDI 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Register Number: 1171216014
Holder Company Name: Samsung Bioepis Nl B.V.
Marketing Company Name: Biogen Spain S.L.
Holder Company Detail Path: /organization/samsung-bioepis-nl-b-v
Authorization Date: 2022-07-21
Dosage Form: SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA
Dose: 40 MG
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Samsung Bioepis Nl B.V.
Company Detail Path: /organization/samsung-bioepis-nl-b-v

Company Information

Pharmaceutical Company Name: Samsung Bioepis NL B.V.
Country Name: Netherlands

Active Ingredients

ADALIMUMAB

40 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 21, 2022

Approval ID

b186b7e17f7539ca

Type

Standard

Back to CIMA-AEMPS Approvals